WIPO trademark

Dazublys (trastuzumab)

MixedWIPOClass 5

"Dazublys (trastuzumab)" is a trademark owned by Curateq Biologics Private Limited., filed at the WIPO on January 29, 2024. It is on file and covers class 5 (Pharmaceuticals).

View Curateq Biologics Private Limited. portfolioGet this data via the API
Dazublys (trastuzumab)
Trademark as filed with the WIPO
Status
Mixed
Filed
January 29, 2024
Registered
Not yet
Expires
January 29, 2034
Application no.
Not recorded
Registration no.
1788919
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns Dazublys (trastuzumab)

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Curateq Biologics Private Limited.

India

8 trademarks in the portfolioView company

Representative

Bharat Daswani

Goods and services

What the mark covers

The products and services Dazublys (trastuzumab) is filed for, grouped by Nice class.

  • Medicinal, pharmaceutical and veterinary preparations including dietary, nutritional and vitamin food supplements.

FAQ

About Dazublys (trastuzumab)

Who owns the trademark "Dazublys (trastuzumab)"?

The WIPO trademark "Dazublys (trastuzumab)" is owned by Curateq Biologics Private Limited.

What is the status of "Dazublys (trastuzumab)"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Dazublys (trastuzumab) and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_bf6e3ec6-96a3-4857-93bd-16e53c6fb1e8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_bf6e3ec6-96a3-4857-93bd-16e53c6fb1e8",
  "object": "trademark",
  "mark_text": "Dazublys (trastuzumab)",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2024-01-29",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "CURATEQ BIOLOGICS PRIVATE LIMITED.",
      "entity_id": "ent_019fcef2-78ae-72df-ad89-53bd9d4cd796"
    }
  ]
}